nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—Ezetimibe—atherosclerosis	0.104	0.267	CbGbCtD
Terazosin—ABCB1—Simvastatin—atherosclerosis	0.0971	0.248	CbGbCtD
Terazosin—ABCB1—Lovastatin—atherosclerosis	0.095	0.243	CbGbCtD
Terazosin—ABCB1—Pravastatin—atherosclerosis	0.095	0.243	CbGbCtD
Terazosin—Depression—Pravastatin—atherosclerosis	0.00176	0.00356	CcSEcCtD
Terazosin—Angioedema—Rosuvastatin—atherosclerosis	0.00176	0.00356	CcSEcCtD
Terazosin—Jaundice—Niacin—atherosclerosis	0.00175	0.00354	CcSEcCtD
Terazosin—Jaundice—Pravastatin—atherosclerosis	0.00172	0.00348	CcSEcCtD
Terazosin—Sweating—Niacin—atherosclerosis	0.00172	0.00348	CcSEcCtD
Terazosin—Urinary tract infection—Pravastatin—atherosclerosis	0.00172	0.00347	CcSEcCtD
Terazosin—Cough—Rosuvastatin—atherosclerosis	0.00168	0.0034	CcSEcCtD
Terazosin—Sinusitis—Pravastatin—atherosclerosis	0.00166	0.00335	CcSEcCtD
Terazosin—Arthralgia—Rosuvastatin—atherosclerosis	0.00164	0.00332	CcSEcCtD
Terazosin—Myalgia—Rosuvastatin—atherosclerosis	0.00164	0.00332	CcSEcCtD
Terazosin—Rhinitis—Niacin—atherosclerosis	0.00161	0.00327	CcSEcCtD
Terazosin—Flatulence—Lovastatin—atherosclerosis	0.00161	0.00325	CcSEcCtD
Terazosin—Malnutrition—Ezetimibe—atherosclerosis	0.0016	0.00324	CcSEcCtD
Terazosin—Dysgeusia—Lovastatin—atherosclerosis	0.0016	0.00323	CcSEcCtD
Terazosin—Rhinitis—Pravastatin—atherosclerosis	0.00159	0.00322	CcSEcCtD
Terazosin—Oedema peripheral—Niacin—atherosclerosis	0.00159	0.00321	CcSEcCtD
Terazosin—Confusional state—Rosuvastatin—atherosclerosis	0.00158	0.00321	CcSEcCtD
Terazosin—Back pain—Lovastatin—atherosclerosis	0.00158	0.00319	CcSEcCtD
Terazosin—Flatulence—Ezetimibe—atherosclerosis	0.00158	0.00319	CcSEcCtD
Terazosin—Pharyngitis—Pravastatin—atherosclerosis	0.00157	0.00318	CcSEcCtD
Terazosin—Visual impairment—Niacin—atherosclerosis	0.00155	0.00314	CcSEcCtD
Terazosin—Back pain—Ezetimibe—atherosclerosis	0.00155	0.00313	CcSEcCtD
Terazosin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00154	0.00311	CcSEcCtD
Terazosin—Vision blurred—Lovastatin—atherosclerosis	0.00154	0.00311	CcSEcCtD
Terazosin—Tremor—Lovastatin—atherosclerosis	0.00153	0.00309	CcSEcCtD
Terazosin—Visual impairment—Pravastatin—atherosclerosis	0.00153	0.00309	CcSEcCtD
Terazosin—Ill-defined disorder—Lovastatin—atherosclerosis	0.00151	0.00306	CcSEcCtD
Terazosin—Eye disorder—Niacin—atherosclerosis	0.0015	0.00304	CcSEcCtD
Terazosin—Flatulence—Simvastatin—atherosclerosis	0.0015	0.00304	CcSEcCtD
Terazosin—Tinnitus—Niacin—atherosclerosis	0.0015	0.00304	CcSEcCtD
Terazosin—Dysgeusia—Simvastatin—atherosclerosis	0.00149	0.00302	CcSEcCtD
Terazosin—Angioedema—Lovastatin—atherosclerosis	0.00149	0.00302	CcSEcCtD
Terazosin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00149	0.00301	CcSEcCtD
Terazosin—Tinnitus—Pravastatin—atherosclerosis	0.00148	0.00299	CcSEcCtD
Terazosin—Malaise—Lovastatin—atherosclerosis	0.00147	0.00298	CcSEcCtD
Terazosin—Vertigo—Lovastatin—atherosclerosis	0.00147	0.00297	CcSEcCtD
Terazosin—Angioedema—Ezetimibe—atherosclerosis	0.00146	0.00296	CcSEcCtD
Terazosin—Malaise—Ezetimibe—atherosclerosis	0.00144	0.00292	CcSEcCtD
Terazosin—Vision blurred—Simvastatin—atherosclerosis	0.00144	0.00291	CcSEcCtD
Terazosin—Arrhythmia—Niacin—atherosclerosis	0.00144	0.00291	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00143	0.0029	CcSEcCtD
Terazosin—Tremor—Simvastatin—atherosclerosis	0.00143	0.00289	CcSEcCtD
Terazosin—Insomnia—Rosuvastatin—atherosclerosis	0.00142	0.00288	CcSEcCtD
Terazosin—Ill-defined disorder—Simvastatin—atherosclerosis	0.00142	0.00287	CcSEcCtD
Terazosin—Arrhythmia—Pravastatin—atherosclerosis	0.00142	0.00287	CcSEcCtD
Terazosin—Palpitations—Ezetimibe—atherosclerosis	0.00141	0.00286	CcSEcCtD
Terazosin—Paraesthesia—Rosuvastatin—atherosclerosis	0.00141	0.00286	CcSEcCtD
Terazosin—Malnutrition—Niacin—atherosclerosis	0.0014	0.00284	CcSEcCtD
Terazosin—Cough—Ezetimibe—atherosclerosis	0.0014	0.00283	CcSEcCtD
Terazosin—Angioedema—Simvastatin—atherosclerosis	0.00139	0.00282	CcSEcCtD
Terazosin—Chest pain—Lovastatin—atherosclerosis	0.00139	0.00281	CcSEcCtD
Terazosin—Myalgia—Lovastatin—atherosclerosis	0.00139	0.00281	CcSEcCtD
Terazosin—Arthralgia—Lovastatin—atherosclerosis	0.00139	0.00281	CcSEcCtD
Terazosin—Anxiety—Lovastatin—atherosclerosis	0.00138	0.0028	CcSEcCtD
Terazosin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00138	0.0028	CcSEcCtD
Terazosin—Flatulence—Niacin—atherosclerosis	0.00138	0.00279	CcSEcCtD
Terazosin—Malaise—Simvastatin—atherosclerosis	0.00138	0.00279	CcSEcCtD
Terazosin—Tension—Niacin—atherosclerosis	0.00138	0.00278	CcSEcCtD
Terazosin—Discomfort—Lovastatin—atherosclerosis	0.00137	0.00278	CcSEcCtD
Terazosin—Vertigo—Simvastatin—atherosclerosis	0.00137	0.00278	CcSEcCtD
Terazosin—Chest pain—Ezetimibe—atherosclerosis	0.00136	0.00276	CcSEcCtD
Terazosin—Myalgia—Ezetimibe—atherosclerosis	0.00136	0.00276	CcSEcCtD
Terazosin—Arthralgia—Ezetimibe—atherosclerosis	0.00136	0.00276	CcSEcCtD
Terazosin—Nervousness—Niacin—atherosclerosis	0.00136	0.00275	CcSEcCtD
Terazosin—Flatulence—Pravastatin—atherosclerosis	0.00136	0.00275	CcSEcCtD
Terazosin—Dry mouth—Lovastatin—atherosclerosis	0.00136	0.00275	CcSEcCtD
Terazosin—Tension—Pravastatin—atherosclerosis	0.00135	0.00274	CcSEcCtD
Terazosin—Dysgeusia—Pravastatin—atherosclerosis	0.00135	0.00273	CcSEcCtD
Terazosin—Discomfort—Ezetimibe—atherosclerosis	0.00135	0.00272	CcSEcCtD
Terazosin—Pain—Rosuvastatin—atherosclerosis	0.00134	0.00272	CcSEcCtD
Terazosin—Constipation—Rosuvastatin—atherosclerosis	0.00134	0.00272	CcSEcCtD
Terazosin—Confusional state—Lovastatin—atherosclerosis	0.00134	0.00272	CcSEcCtD
Terazosin—Nervousness—Pravastatin—atherosclerosis	0.00134	0.00271	CcSEcCtD
Terazosin—Dry mouth—Ezetimibe—atherosclerosis	0.00133	0.0027	CcSEcCtD
Terazosin—Anaphylactic shock—Lovastatin—atherosclerosis	0.00133	0.0027	CcSEcCtD
Terazosin—Vision blurred—Niacin—atherosclerosis	0.00132	0.00267	CcSEcCtD
Terazosin—Confusional state—Ezetimibe—atherosclerosis	0.00132	0.00267	CcSEcCtD
Terazosin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00131	0.00264	CcSEcCtD
Terazosin—Thrombocytopenia—Lovastatin—atherosclerosis	0.0013	0.00264	CcSEcCtD
Terazosin—Vision blurred—Pravastatin—atherosclerosis	0.0013	0.00263	CcSEcCtD
Terazosin—Arthralgia—Simvastatin—atherosclerosis	0.0013	0.00263	CcSEcCtD
Terazosin—Chest pain—Simvastatin—atherosclerosis	0.0013	0.00263	CcSEcCtD
Terazosin—Myalgia—Simvastatin—atherosclerosis	0.0013	0.00263	CcSEcCtD
Terazosin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0013	0.00262	CcSEcCtD
Terazosin—Anxiety—Simvastatin—atherosclerosis	0.0013	0.00262	CcSEcCtD
Terazosin—Tremor—Pravastatin—atherosclerosis	0.00129	0.00262	CcSEcCtD
Terazosin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00129	0.0026	CcSEcCtD
Terazosin—Discomfort—Simvastatin—atherosclerosis	0.00128	0.0026	CcSEcCtD
Terazosin—Angioedema—Niacin—atherosclerosis	0.00128	0.00259	CcSEcCtD
Terazosin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00128	0.00259	CcSEcCtD
Terazosin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00128	0.00259	CcSEcCtD
Terazosin—Anorexia—Lovastatin—atherosclerosis	0.00127	0.00257	CcSEcCtD
Terazosin—Angioedema—Pravastatin—atherosclerosis	0.00126	0.00255	CcSEcCtD
Terazosin—Vertigo—Niacin—atherosclerosis	0.00126	0.00255	CcSEcCtD
Terazosin—Syncope—Niacin—atherosclerosis	0.00126	0.00254	CcSEcCtD
Terazosin—Confusional state—Simvastatin—atherosclerosis	0.00126	0.00254	CcSEcCtD
Terazosin—Anaphylactic shock—Simvastatin—atherosclerosis	0.00125	0.00252	CcSEcCtD
Terazosin—Oedema—Simvastatin—atherosclerosis	0.00125	0.00252	CcSEcCtD
Terazosin—Malaise—Pravastatin—atherosclerosis	0.00124	0.00252	CcSEcCtD
Terazosin—Abdominal pain—Rosuvastatin—atherosclerosis	0.00124	0.00251	CcSEcCtD
Terazosin—Vertigo—Pravastatin—atherosclerosis	0.00124	0.00251	CcSEcCtD
Terazosin—Palpitations—Niacin—atherosclerosis	0.00124	0.00251	CcSEcCtD
Terazosin—Loss of consciousness—Niacin—atherosclerosis	0.00123	0.00249	CcSEcCtD
Terazosin—Cough—Niacin—atherosclerosis	0.00122	0.00248	CcSEcCtD
Terazosin—Thrombocytopenia—Simvastatin—atherosclerosis	0.00122	0.00247	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00121	0.00246	CcSEcCtD
Terazosin—Insomnia—Lovastatin—atherosclerosis	0.0012	0.00244	CcSEcCtD
Terazosin—Cough—Pravastatin—atherosclerosis	0.0012	0.00244	CcSEcCtD
Terazosin—Paraesthesia—Lovastatin—atherosclerosis	0.0012	0.00242	CcSEcCtD
Terazosin—Arthralgia—Niacin—atherosclerosis	0.00119	0.00241	CcSEcCtD
Terazosin—Myalgia—Niacin—atherosclerosis	0.00119	0.00241	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00119	0.00241	CcSEcCtD
Terazosin—Anorexia—Simvastatin—atherosclerosis	0.00119	0.0024	CcSEcCtD
Terazosin—Dyspnoea—Lovastatin—atherosclerosis	0.00119	0.0024	CcSEcCtD
Terazosin—Insomnia—Ezetimibe—atherosclerosis	0.00118	0.00239	CcSEcCtD
Terazosin—Chest pain—Pravastatin—atherosclerosis	0.00117	0.00238	CcSEcCtD
Terazosin—Arthralgia—Pravastatin—atherosclerosis	0.00117	0.00238	CcSEcCtD
Terazosin—Myalgia—Pravastatin—atherosclerosis	0.00117	0.00238	CcSEcCtD
Terazosin—Paraesthesia—Ezetimibe—atherosclerosis	0.00117	0.00237	CcSEcCtD
Terazosin—Dyspepsia—Lovastatin—atherosclerosis	0.00117	0.00237	CcSEcCtD
Terazosin—Anxiety—Pravastatin—atherosclerosis	0.00117	0.00237	CcSEcCtD
Terazosin—Dry mouth—Niacin—atherosclerosis	0.00117	0.00236	CcSEcCtD
Terazosin—Dyspnoea—Ezetimibe—atherosclerosis	0.00116	0.00236	CcSEcCtD
Terazosin—Discomfort—Pravastatin—atherosclerosis	0.00116	0.00235	CcSEcCtD
Terazosin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00116	0.00234	CcSEcCtD
Terazosin—Decreased appetite—Lovastatin—atherosclerosis	0.00116	0.00234	CcSEcCtD
Terazosin—Dyspepsia—Ezetimibe—atherosclerosis	0.00115	0.00233	CcSEcCtD
Terazosin—Fatigue—Lovastatin—atherosclerosis	0.00115	0.00232	CcSEcCtD
Terazosin—Anaphylactic shock—Niacin—atherosclerosis	0.00114	0.00231	CcSEcCtD
Terazosin—Oedema—Niacin—atherosclerosis	0.00114	0.00231	CcSEcCtD
Terazosin—Pain—Lovastatin—atherosclerosis	0.00114	0.0023	CcSEcCtD
Terazosin—Constipation—Lovastatin—atherosclerosis	0.00114	0.0023	CcSEcCtD
Terazosin—Confusional state—Pravastatin—atherosclerosis	0.00114	0.0023	CcSEcCtD
Terazosin—Decreased appetite—Ezetimibe—atherosclerosis	0.00114	0.0023	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00113	0.0023	CcSEcCtD
Terazosin—Asthenia—Rosuvastatin—atherosclerosis	0.00113	0.00228	CcSEcCtD
Terazosin—Insomnia—Simvastatin—atherosclerosis	0.00113	0.00228	CcSEcCtD
Terazosin—Anaphylactic shock—Pravastatin—atherosclerosis	0.00113	0.00228	CcSEcCtD
Terazosin—Oedema—Pravastatin—atherosclerosis	0.00113	0.00228	CcSEcCtD
Terazosin—Fatigue—Ezetimibe—atherosclerosis	0.00113	0.00228	CcSEcCtD
Terazosin—Shock—Niacin—atherosclerosis	0.00113	0.00228	CcSEcCtD
Terazosin—Paraesthesia—Simvastatin—atherosclerosis	0.00112	0.00226	CcSEcCtD
Terazosin—Pain—Ezetimibe—atherosclerosis	0.00112	0.00226	CcSEcCtD
Terazosin—Constipation—Ezetimibe—atherosclerosis	0.00112	0.00226	CcSEcCtD
Terazosin—Tachycardia—Niacin—atherosclerosis	0.00112	0.00226	CcSEcCtD
Terazosin—Pruritus—Rosuvastatin—atherosclerosis	0.00111	0.00225	CcSEcCtD
Terazosin—Dyspnoea—Simvastatin—atherosclerosis	0.00111	0.00225	CcSEcCtD
Terazosin—Hyperhidrosis—Niacin—atherosclerosis	0.00111	0.00224	CcSEcCtD
Terazosin—Thrombocytopenia—Pravastatin—atherosclerosis	0.0011	0.00223	CcSEcCtD
Terazosin—Feeling abnormal—Lovastatin—atherosclerosis	0.0011	0.00222	CcSEcCtD
Terazosin—Dyspepsia—Simvastatin—atherosclerosis	0.0011	0.00222	CcSEcCtD
Terazosin—Anorexia—Niacin—atherosclerosis	0.00109	0.00221	CcSEcCtD
Terazosin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00109	0.0022	CcSEcCtD
Terazosin—Hyperhidrosis—Pravastatin—atherosclerosis	0.00109	0.0022	CcSEcCtD
Terazosin—Decreased appetite—Simvastatin—atherosclerosis	0.00108	0.00219	CcSEcCtD
Terazosin—Feeling abnormal—Ezetimibe—atherosclerosis	0.00108	0.00218	CcSEcCtD
Terazosin—Diarrhoea—Rosuvastatin—atherosclerosis	0.00108	0.00218	CcSEcCtD
Terazosin—Fatigue—Simvastatin—atherosclerosis	0.00107	0.00217	CcSEcCtD
Terazosin—Anorexia—Pravastatin—atherosclerosis	0.00107	0.00217	CcSEcCtD
Terazosin—Hypotension—Niacin—atherosclerosis	0.00107	0.00216	CcSEcCtD
Terazosin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00107	0.00216	CcSEcCtD
Terazosin—Pain—Simvastatin—atherosclerosis	0.00107	0.00216	CcSEcCtD
Terazosin—Constipation—Simvastatin—atherosclerosis	0.00107	0.00216	CcSEcCtD
Terazosin—Body temperature increased—Lovastatin—atherosclerosis	0.00105	0.00213	CcSEcCtD
Terazosin—Abdominal pain—Lovastatin—atherosclerosis	0.00105	0.00213	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00104	0.00211	CcSEcCtD
Terazosin—Dizziness—Rosuvastatin—atherosclerosis	0.00104	0.0021	CcSEcCtD
Terazosin—Insomnia—Niacin—atherosclerosis	0.00103	0.00209	CcSEcCtD
Terazosin—Abdominal pain—Ezetimibe—atherosclerosis	0.00103	0.00209	CcSEcCtD
Terazosin—Body temperature increased—Ezetimibe—atherosclerosis	0.00103	0.00209	CcSEcCtD
Terazosin—Paraesthesia—Niacin—atherosclerosis	0.00103	0.00208	CcSEcCtD
Terazosin—Feeling abnormal—Simvastatin—atherosclerosis	0.00103	0.00208	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00103	0.00208	CcSEcCtD
Terazosin—Dyspnoea—Niacin—atherosclerosis	0.00102	0.00206	CcSEcCtD
Terazosin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00102	0.00206	CcSEcCtD
Terazosin—Insomnia—Pravastatin—atherosclerosis	0.00102	0.00206	CcSEcCtD
Terazosin—Somnolence—Niacin—atherosclerosis	0.00102	0.00206	CcSEcCtD
Terazosin—Paraesthesia—Pravastatin—atherosclerosis	0.00101	0.00205	CcSEcCtD
Terazosin—Dyspepsia—Niacin—atherosclerosis	0.00101	0.00204	CcSEcCtD
Terazosin—Dyspnoea—Pravastatin—atherosclerosis	0.001	0.00203	CcSEcCtD
Terazosin—Decreased appetite—Niacin—atherosclerosis	0.000994	0.00201	CcSEcCtD
Terazosin—Dyspepsia—Pravastatin—atherosclerosis	0.000991	0.00201	CcSEcCtD
Terazosin—Rash—Rosuvastatin—atherosclerosis	0.000991	0.00201	CcSEcCtD
Terazosin—Dermatitis—Rosuvastatin—atherosclerosis	0.00099	0.002	CcSEcCtD
Terazosin—Abdominal pain—Simvastatin—atherosclerosis	0.000985	0.00199	CcSEcCtD
Terazosin—Body temperature increased—Simvastatin—atherosclerosis	0.000985	0.00199	CcSEcCtD
Terazosin—Headache—Rosuvastatin—atherosclerosis	0.000985	0.00199	CcSEcCtD
Terazosin—Hypersensitivity—Lovastatin—atherosclerosis	0.000981	0.00199	CcSEcCtD
Terazosin—Decreased appetite—Pravastatin—atherosclerosis	0.000979	0.00198	CcSEcCtD
Terazosin—Pain—Niacin—atherosclerosis	0.000978	0.00198	CcSEcCtD
Terazosin—Fatigue—Pravastatin—atherosclerosis	0.000971	0.00196	CcSEcCtD
Terazosin—Pain—Pravastatin—atherosclerosis	0.000963	0.00195	CcSEcCtD
Terazosin—Constipation—Pravastatin—atherosclerosis	0.000963	0.00195	CcSEcCtD
Terazosin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000962	0.00195	CcSEcCtD
Terazosin—Asthenia—Lovastatin—atherosclerosis	0.000956	0.00193	CcSEcCtD
Terazosin—Pruritus—Lovastatin—atherosclerosis	0.000942	0.00191	CcSEcCtD
Terazosin—Asthenia—Ezetimibe—atherosclerosis	0.000937	0.0019	CcSEcCtD
Terazosin—Gastrointestinal pain—Niacin—atherosclerosis	0.000935	0.00189	CcSEcCtD
Terazosin—Nausea—Rosuvastatin—atherosclerosis	0.000933	0.00189	CcSEcCtD
Terazosin—Feeling abnormal—Pravastatin—atherosclerosis	0.000928	0.00188	CcSEcCtD
Terazosin—Pruritus—Ezetimibe—atherosclerosis	0.000924	0.00187	CcSEcCtD
Terazosin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000921	0.00186	CcSEcCtD
Terazosin—Hypersensitivity—Simvastatin—atherosclerosis	0.000918	0.00186	CcSEcCtD
Terazosin—Diarrhoea—Lovastatin—atherosclerosis	0.000911	0.00184	CcSEcCtD
Terazosin—Abdominal pain—Niacin—atherosclerosis	0.000904	0.00183	CcSEcCtD
Terazosin—Body temperature increased—Niacin—atherosclerosis	0.000904	0.00183	CcSEcCtD
Terazosin—Asthenia—Simvastatin—atherosclerosis	0.000894	0.00181	CcSEcCtD
Terazosin—Diarrhoea—Ezetimibe—atherosclerosis	0.000894	0.00181	CcSEcCtD
Terazosin—Abdominal pain—Pravastatin—atherosclerosis	0.00089	0.0018	CcSEcCtD
Terazosin—Body temperature increased—Pravastatin—atherosclerosis	0.00089	0.0018	CcSEcCtD
Terazosin—Pruritus—Simvastatin—atherosclerosis	0.000881	0.00178	CcSEcCtD
Terazosin—Dizziness—Lovastatin—atherosclerosis	0.000881	0.00178	CcSEcCtD
Terazosin—Dizziness—Ezetimibe—atherosclerosis	0.000864	0.00175	CcSEcCtD
Terazosin—Diarrhoea—Simvastatin—atherosclerosis	0.000852	0.00172	CcSEcCtD
Terazosin—Vomiting—Lovastatin—atherosclerosis	0.000847	0.00171	CcSEcCtD
Terazosin—Hypersensitivity—Niacin—atherosclerosis	0.000843	0.00171	CcSEcCtD
Terazosin—Rash—Lovastatin—atherosclerosis	0.00084	0.0017	CcSEcCtD
Terazosin—Dermatitis—Lovastatin—atherosclerosis	0.000839	0.0017	CcSEcCtD
Terazosin—Headache—Lovastatin—atherosclerosis	0.000834	0.00169	CcSEcCtD
Terazosin—Vomiting—Ezetimibe—atherosclerosis	0.000831	0.00168	CcSEcCtD
Terazosin—Hypersensitivity—Pravastatin—atherosclerosis	0.00083	0.00168	CcSEcCtD
Terazosin—Dizziness—Simvastatin—atherosclerosis	0.000824	0.00167	CcSEcCtD
Terazosin—Rash—Ezetimibe—atherosclerosis	0.000824	0.00167	CcSEcCtD
Terazosin—Dermatitis—Ezetimibe—atherosclerosis	0.000823	0.00167	CcSEcCtD
Terazosin—Asthenia—Niacin—atherosclerosis	0.000821	0.00166	CcSEcCtD
Terazosin—Headache—Ezetimibe—atherosclerosis	0.000818	0.00166	CcSEcCtD
Terazosin—Pruritus—Niacin—atherosclerosis	0.000809	0.00164	CcSEcCtD
Terazosin—Asthenia—Pravastatin—atherosclerosis	0.000808	0.00164	CcSEcCtD
Terazosin—Pruritus—Pravastatin—atherosclerosis	0.000797	0.00161	CcSEcCtD
Terazosin—Vomiting—Simvastatin—atherosclerosis	0.000792	0.0016	CcSEcCtD
Terazosin—Nausea—Lovastatin—atherosclerosis	0.000791	0.0016	CcSEcCtD
Terazosin—Rash—Simvastatin—atherosclerosis	0.000785	0.00159	CcSEcCtD
Terazosin—Dermatitis—Simvastatin—atherosclerosis	0.000785	0.00159	CcSEcCtD
Terazosin—Diarrhoea—Niacin—atherosclerosis	0.000783	0.00158	CcSEcCtD
Terazosin—Headache—Simvastatin—atherosclerosis	0.00078	0.00158	CcSEcCtD
Terazosin—Nausea—Ezetimibe—atherosclerosis	0.000776	0.00157	CcSEcCtD
Terazosin—Diarrhoea—Pravastatin—atherosclerosis	0.000771	0.00156	CcSEcCtD
Terazosin—Dizziness—Niacin—atherosclerosis	0.000756	0.00153	CcSEcCtD
Terazosin—Dizziness—Pravastatin—atherosclerosis	0.000745	0.00151	CcSEcCtD
Terazosin—Nausea—Simvastatin—atherosclerosis	0.00074	0.0015	CcSEcCtD
Terazosin—Vomiting—Niacin—atherosclerosis	0.000727	0.00147	CcSEcCtD
Terazosin—Rash—Niacin—atherosclerosis	0.000721	0.00146	CcSEcCtD
Terazosin—Dermatitis—Niacin—atherosclerosis	0.000721	0.00146	CcSEcCtD
Terazosin—Headache—Niacin—atherosclerosis	0.000717	0.00145	CcSEcCtD
Terazosin—Vomiting—Pravastatin—atherosclerosis	0.000716	0.00145	CcSEcCtD
Terazosin—Rash—Pravastatin—atherosclerosis	0.00071	0.00144	CcSEcCtD
Terazosin—Dermatitis—Pravastatin—atherosclerosis	0.000709	0.00144	CcSEcCtD
Terazosin—Headache—Pravastatin—atherosclerosis	0.000706	0.00143	CcSEcCtD
Terazosin—Nausea—Niacin—atherosclerosis	0.000679	0.00137	CcSEcCtD
Terazosin—Nausea—Pravastatin—atherosclerosis	0.000669	0.00135	CcSEcCtD
Terazosin—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	5.19e-05	0.000454	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	5.18e-05	0.000454	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	5.18e-05	0.000453	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	5.18e-05	0.000453	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NCF1—atherosclerosis	5.17e-05	0.000452	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PRKCG—atherosclerosis	5.13e-05	0.000449	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	5.09e-05	0.000446	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—F2—atherosclerosis	5.03e-05	0.00044	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	4.98e-05	0.000435	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CASR—atherosclerosis	4.98e-05	0.000435	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LCAT—atherosclerosis	4.95e-05	0.000433	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—FABP4—atherosclerosis	4.95e-05	0.000433	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AGT—atherosclerosis	4.94e-05	0.000432	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—EDN1—atherosclerosis	4.94e-05	0.000432	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL5—atherosclerosis	4.9e-05	0.000429	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	4.89e-05	0.000428	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	4.88e-05	0.000427	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCR2—atherosclerosis	4.88e-05	0.000427	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EDNRA—atherosclerosis	4.88e-05	0.000427	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CYBA—atherosclerosis	4.86e-05	0.000425	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA4—atherosclerosis	4.86e-05	0.000425	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	4.83e-05	0.000423	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—PIK3CG—atherosclerosis	4.81e-05	0.000421	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	4.8e-05	0.00042	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP7A1—atherosclerosis	4.77e-05	0.000417	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—GHRL—atherosclerosis	4.76e-05	0.000416	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PARP1—atherosclerosis	4.76e-05	0.000416	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLAT—atherosclerosis	4.76e-05	0.000416	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	4.7e-05	0.000412	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PRKCG—atherosclerosis	4.66e-05	0.000408	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VWF—atherosclerosis	4.64e-05	0.000406	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	4.63e-05	0.000405	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	4.62e-05	0.000405	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	4.62e-05	0.000404	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOC3—atherosclerosis	4.61e-05	0.000404	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	4.61e-05	0.000403	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LDLR—atherosclerosis	4.58e-05	0.000401	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—F2—atherosclerosis	4.57e-05	0.0004	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	4.56e-05	0.000399	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AGT—atherosclerosis	4.52e-05	0.000395	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.51e-05	0.000395	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL3—atherosclerosis	4.48e-05	0.000392	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	4.45e-05	0.000389	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CYP27A1—atherosclerosis	4.41e-05	0.000386	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	4.39e-05	0.000384	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—PIK3CG—atherosclerosis	4.37e-05	0.000382	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	4.36e-05	0.000381	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	4.32e-05	0.000378	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	4.32e-05	0.000378	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NCF1—atherosclerosis	4.29e-05	0.000375	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLA2G2A—atherosclerosis	4.18e-05	0.000366	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA2—atherosclerosis	4.18e-05	0.000366	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALOX5AP—atherosclerosis	4.18e-05	0.000366	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALOX15—atherosclerosis	4.18e-05	0.000366	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—F2—atherosclerosis	4.17e-05	0.000365	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—KNG1—atherosclerosis	4.17e-05	0.000365	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGTR1—atherosclerosis	4.15e-05	0.000363	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	4.14e-05	0.000362	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCG5—atherosclerosis	4.13e-05	0.000361	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VWF—atherosclerosis	4.12e-05	0.000361	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AGT—atherosclerosis	4.1e-05	0.000359	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	4.1e-05	0.000359	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	4.07e-05	0.000356	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CCL2—atherosclerosis	4.07e-05	0.000356	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EDNRA—atherosclerosis	4.05e-05	0.000354	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCR2—atherosclerosis	4.05e-05	0.000354	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PLG—atherosclerosis	4.04e-05	0.000354	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CYBA—atherosclerosis	4.03e-05	0.000353	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	4.03e-05	0.000353	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	4.01e-05	0.000351	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—PIK3CG—atherosclerosis	3.99e-05	0.00035	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LPA—atherosclerosis	3.99e-05	0.000349	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	3.98e-05	0.000348	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLAT—atherosclerosis	3.95e-05	0.000345	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PARP1—atherosclerosis	3.95e-05	0.000345	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—GHRL—atherosclerosis	3.95e-05	0.000345	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—BGN—atherosclerosis	3.86e-05	0.000338	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SOCS3—atherosclerosis	3.83e-05	0.000335	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA5—atherosclerosis	3.82e-05	0.000335	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	3.81e-05	0.000333	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—F2—atherosclerosis	3.79e-05	0.000332	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	3.71e-05	0.000324	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP3—atherosclerosis	3.7e-05	0.000324	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF2—atherosclerosis	3.68e-05	0.000322	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PLA2G1B—atherosclerosis	3.68e-05	0.000322	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.65e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	3.64e-05	0.000319	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—PIK3CG—atherosclerosis	3.63e-05	0.000317	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	3.6e-05	0.000315	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	3.6e-05	0.000315	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	3.58e-05	0.000313	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOB—atherosclerosis	3.57e-05	0.000313	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALOX5—atherosclerosis	3.55e-05	0.000311	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	3.55e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—CXCL8—atherosclerosis	3.54e-05	0.00031	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—EDN1—atherosclerosis	3.52e-05	0.000308	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	3.51e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	3.51e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	3.51e-05	0.000307	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL5—atherosclerosis	3.49e-05	0.000305	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—KNG1—atherosclerosis	3.46e-05	0.000303	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGTR1—atherosclerosis	3.44e-05	0.000301	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.42e-05	0.000299	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LPL—atherosclerosis	3.41e-05	0.000299	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CCL2—atherosclerosis	3.38e-05	0.000296	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—F2—atherosclerosis	3.37e-05	0.000295	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PLG—atherosclerosis	3.36e-05	0.000294	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PRKCG—atherosclerosis	3.32e-05	0.00029	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SPP1—atherosclerosis	3.23e-05	0.000283	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	3.22e-05	0.000282	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—CXCL8—atherosclerosis	3.22e-05	0.000282	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NAMPT—atherosclerosis	3.19e-05	0.000279	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SOCS3—atherosclerosis	3.18e-05	0.000278	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LIPC—atherosclerosis	3.17e-05	0.000277	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOC3—atherosclerosis	3.15e-05	0.000276	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LDLR—atherosclerosis	3.13e-05	0.000274	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	3.08e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP3—atherosclerosis	3.07e-05	0.000269	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	3.06e-05	0.000268	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CETP—atherosclerosis	3.06e-05	0.000267	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF2—atherosclerosis	3.06e-05	0.000267	CbGpPWpGaD
Terazosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	3e-05	0.000263	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PDGFB—atherosclerosis	2.99e-05	0.000262	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PLG—atherosclerosis	2.98e-05	0.000261	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOB—atherosclerosis	2.97e-05	0.00026	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—CXCL8—atherosclerosis	2.94e-05	0.000257	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—SCARB1—atherosclerosis	2.93e-05	0.000256	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AGT—atherosclerosis	2.92e-05	0.000255	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—EDN1—atherosclerosis	2.92e-05	0.000255	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL5—atherosclerosis	2.9e-05	0.000253	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—LEP—atherosclerosis	2.86e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOE—atherosclerosis	2.86e-05	0.00025	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CAV1—atherosclerosis	2.83e-05	0.000248	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LPL—atherosclerosis	2.83e-05	0.000248	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—APOA1—atherosclerosis	2.83e-05	0.000247	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	2.82e-05	0.000247	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMGCR—atherosclerosis	2.76e-05	0.000242	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PRKCG—atherosclerosis	2.75e-05	0.000241	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—ESR1—atherosclerosis	2.73e-05	0.000239	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	2.73e-05	0.000239	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	2.71e-05	0.000238	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	2.71e-05	0.000237	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—F2—atherosclerosis	2.7e-05	0.000236	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SPP1—atherosclerosis	2.68e-05	0.000235	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—CXCL8—atherosclerosis	2.67e-05	0.000234	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOB—atherosclerosis	2.63e-05	0.000231	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	2.61e-05	0.000229	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	2.59e-05	0.000227	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—PIK3CG—atherosclerosis	2.58e-05	0.000226	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	2.57e-05	0.000225	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LPL—atherosclerosis	2.52e-05	0.00022	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PDGFB—atherosclerosis	2.48e-05	0.000217	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—MAPK3—atherosclerosis	2.47e-05	0.000216	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ABCA1—atherosclerosis	2.46e-05	0.000216	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	2.45e-05	0.000214	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—INS—atherosclerosis	2.44e-05	0.000214	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AGT—atherosclerosis	2.42e-05	0.000212	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CCL2—atherosclerosis	2.4e-05	0.00021	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	2.38e-05	0.000209	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—LEP—atherosclerosis	2.37e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOE—atherosclerosis	2.37e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	2.37e-05	0.000208	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IGF1—atherosclerosis	2.36e-05	0.000207	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CAV1—atherosclerosis	2.35e-05	0.000206	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—APOA1—atherosclerosis	2.35e-05	0.000205	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—ESR1—atherosclerosis	2.27e-05	0.000198	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—SERPINE1—atherosclerosis	2.24e-05	0.000196	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—F2—atherosclerosis	2.24e-05	0.000196	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	2.2e-05	0.000193	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AGT—atherosclerosis	2.15e-05	0.000188	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	2.14e-05	0.000188	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	2.14e-05	0.000188	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HMOX1—atherosclerosis	2.11e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOE—atherosclerosis	2.11e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—LEP—atherosclerosis	2.11e-05	0.000185	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	2.09e-05	0.000183	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	2.08e-05	0.000182	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	2.05e-05	0.00018	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—INS—atherosclerosis	2.03e-05	0.000177	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOB—atherosclerosis	2.02e-05	0.000177	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	2.01e-05	0.000176	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	2e-05	0.000175	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—F2—atherosclerosis	1.99e-05	0.000174	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GSTM1—atherosclerosis	1.97e-05	0.000172	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	1.96e-05	0.000172	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—LPL—atherosclerosis	1.93e-05	0.000169	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	1.9e-05	0.000167	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	1.9e-05	0.000166	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—GPX1—atherosclerosis	1.89e-05	0.000165	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	1.86e-05	0.000163	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CD36—atherosclerosis	1.84e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	1.84e-05	0.000161	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	1.82e-05	0.00016	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	1.81e-05	0.000158	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—INS—atherosclerosis	1.8e-05	0.000158	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	1.78e-05	0.000156	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	1.77e-05	0.000155	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	1.74e-05	0.000152	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—MTHFR—atherosclerosis	1.74e-05	0.000152	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	1.72e-05	0.00015	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARA—atherosclerosis	1.71e-05	0.000149	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	1.7e-05	0.000149	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	1.67e-05	0.000146	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	1.67e-05	0.000146	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	1.65e-05	0.000145	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AGT—atherosclerosis	1.65e-05	0.000145	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOE—atherosclerosis	1.62e-05	0.000142	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—CAV1—atherosclerosis	1.61e-05	0.00014	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—APOA1—atherosclerosis	1.6e-05	0.00014	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	1.58e-05	0.000138	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	1.58e-05	0.000138	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	1.54e-05	0.000135	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	1.53e-05	0.000134	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	1.52e-05	0.000133	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	1.5e-05	0.000131	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PIK3CG—atherosclerosis	1.46e-05	0.000128	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	1.46e-05	0.000128	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	1.43e-05	0.000125	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	1.42e-05	0.000124	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	1.41e-05	0.000124	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PPARG—atherosclerosis	1.41e-05	0.000124	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.4e-05	0.000123	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	1.39e-05	0.000121	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—INS—atherosclerosis	1.38e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	1.38e-05	0.000121	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.35e-05	0.000118	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.33e-05	0.000117	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	1.28e-05	0.000112	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—ALB—atherosclerosis	1.27e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	1.27e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.27e-05	0.000111	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.25e-05	0.00011	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.23e-05	0.000108	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.23e-05	0.000108	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—NOS3—atherosclerosis	1.21e-05	0.000106	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	1.21e-05	0.000106	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	1.18e-05	0.000103	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.14e-05	9.96e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.13e-05	9.86e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—PTGS2—atherosclerosis	1.11e-05	9.72e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.08e-05	9.42e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—IL6—atherosclerosis	1.07e-05	9.34e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.04e-05	9.14e-05	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	9.85e-06	8.62e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—IL6—atherosclerosis	8.86e-06	7.76e-05	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	8.18e-06	7.16e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—IL6—atherosclerosis	7.87e-06	6.89e-05	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	7.26e-06	6.36e-05	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—AKT1—atherosclerosis	5.58e-06	4.88e-05	CbGpPWpGaD
